Halozyme Therapeutics, Inc.
HALO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001159036
In the last 90 days, Halozyme Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 674 institutions reported holding it in 13F filings for Q2 2026, worth $9.62B in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Halozyme Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 316 | 8 | 368 | +60 |
| Shares | 128.4M | 606.2K | 128.3M | +586.0K (+0.5%) |
| Value | $5.12B | $24.2M | $5.65B | +$556.6M (+10.9%) |
8 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (86)
Institutions that held Halozyme Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
Sold out (26)
Institutions that held Halozyme Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Point72 Asset Management, L.P. | 259,400 | $10.3M |
| Third Security, LLC | 161,452 | $6.44M |
| Winton Group Ltd | 124,869 | $4.98M |
| Stanley-Laman Group, Ltd. | 63,196 | $2.52M |
| Jennison Associates LLC | 29,658 | $1.18M |
| Aaron Wealth Advisors | 32,980 | $827.0K |
| Pzena Investment Management LLC | 15,738 | $628.0K |
| Jefferies Group LLC | 14,797 | $590.1K |
| Duality Advisers, LP | 12,113 | $483.0K |
| Trexquant Investment LP | 7,452 | $297.0K |
| FORA Capital, LLC | 6,402 | $257.0K |
| Argent Capital Management LLC | 6,170 | $246.0K |
| AXA S.A. | 5,200 | $207.4K |
| Morningstar Investment Services LLC | 5,012 | $202.0K |
| Econ Financial Services Corp | 1,000 | $40.0K |
| San Luis Wealth Advisors LLC | 884 | $36.0K |
| Canada Pension Plan Investment Board | 257 | $10.0K |
| EverSource Wealth Advisors, LLC | 215 | $9.00K |
| Prospera Financial Services Inc | 170 | $7.00K |
| Whittier Trust Co | 41 | $2.00K |
| Tarbox Family Office, Inc. | 50 | $2.00K |
| Providence Capital Advisors, LLC | 41 | $2.00K |
| Lloyd Advisory Services, LLC. | 14 | $1.00K |
| Cordant, Inc. | 34 | $1.00K |
| Money Concepts Capital Corp | 3 | $0 |
| TCWP LLC | 9 | $0 |
Not filed for Q2 2022 yet (8)
Institutions that held Halozyme Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 292,933 | $11.7M |
| Amalgamated Financial Corp. | 95,308 | $3.80M |
| Myriad Asset Management Ltd. | 77,000 | $3.07M |
| Doheny Asset Management | 59,791 | $2.38M |
| Virginia Retirement Systems Et Al | 33,000 | $1.32M |
| Verity Asset Management, Inc. | 31,296 | $1.25M |
| Teachers Retirement System of the State of Kentucky | 16,900 | $674.0K |
| SJS Investment Consulting Inc. | 3 | $0 |